DIABETIC RETINOPATHY (DR)
Clinical trials for DIABETIC RETINOPATHY (DR) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC RETINOPATHY (DR) trials appear
Sign up with your email to follow new studies for DIABETIC RETINOPATHY (DR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could free patients from monthly eye injections
Disease control OngoingThis study is testing a potential one-time gene therapy called RGX-314 for diabetic retinopathy, a leading cause of vision loss. The goal is to see if a single injection can slow or reverse the eye damage caused by diabetes, reducing the need for the frequent eye injections that …
Matched conditions: DIABETIC RETINOPATHY (DR)
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
AI camera spots diabetic eye damage in 5 minutes
Diagnosis OngoingThis study is testing whether artificial intelligence (AI) can make diabetic eye screenings quicker and easier to access. Researchers are comparing a fast AI camera system that gives results in minutes against traditional eye exams that require separate appointments. The goal is …
Matched conditions: DIABETIC RETINOPATHY (DR)
Phase: NA • Sponsor: Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Researchers track Real-World results of eye treatments
Knowledge-focused OngoingThis study is observing how 300 patients with glaucoma, age-related macular degeneration (AMD), or diabetic retinopathy respond to treatments in real-world settings. Researchers are tracking changes in eye pressure, vision, and other measures over time. The goal is to compare the…
Matched conditions: DIABETIC RETINOPATHY (DR)
Sponsor: Interstat LLC • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
New eye scanner could spot vision loss before you notice it
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing a special eye scanner called the MAIA device to see if it can detect early vision changes in people with dry age-related macular degeneration (AMD) or diabetic retinopathy. Researchers will measure how sensitive the back of the eye is to light and track chan…
Matched conditions: DIABETIC RETINOPATHY (DR)
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC